b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="In-Process" Owner="NLM">\n        <PMID Version="1">31444566</PMID>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>23</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1433-8491</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>270</Volume>\n                    <Issue>1</Issue>\n                    <PubDate>\n                        <Year>2020</Year>\n                        <Month>Feb</Month>\n                    </PubDate>\n                </JournalIssue>\n                <Title>European archives of psychiatry and clinical neuroscience</Title>\n                <ISOAbbreviation>Eur Arch Psychiatry Clin Neurosci</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Severe parkinsonism under treatment with antipsychotic drugs.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>35-47</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1007/s00406-019-01060-7</ELocationID>\n            <Abstract>\n                <AbstractText>The aim of the study was to assess rates of severe parkinsonism related to different antipsychotic drugs (APDs) using data from an observational pharmacovigilance programme in German-speaking countries-Arzneimittelsicherheit in der Psychiatrie (AMSP). Data on APD utilization and reports of severe APD-induced parkinsonism were collected in 99 psychiatric hospitals in Austria, Germany and Switzerland during the period 2001-2016. Of 340,099 patients under surveillance, 245,958 patients were treated with APDs for the main indications of schizophrenic disorders, depression, mania and organic mental disorders. A total of 200 events of severe APD-induced parkinsonism were identified (0.08%). First-generation low-potency APDs were significantly less often implicated (0.02%) than second-generation APDs (0.07%) and first-generation high-potency APDs (0.16%). Among the second-generation APDs, amisulpride and risperidone ranked highest. The phenothiazines were associated with significantly lower rates of severe parkinsonism (0.02%) than those of the butyrophenones (0.11%) and thioxanthenes (0.12%). In 71 cases (35.5%), more than 1 drug was considered responsible for the induction of severe parkinsonism. In 44 patients (22.0%), the symptoms were extremely severe, leading to complete immobility and/or massive complications such as pneumonia and severe injuries due to falls. Higher age (&gt;\xe2\x80\x8960\xc2\xa0years) was associated with significantly higher rates of severe parkinsonism, as were the diagnoses of schizophrenic disorder or mania. The large number of patients included in the present survey allows for the comparison of severe parkinsonism rates related to different APD classes and single APDs. The first-generation low-potency APDs had significantly reduced risk of severe parkinsonism compared not only to high potency but also to second-generation APDs.</AbstractText>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Druschky</LastName>\n                    <ForeName>Katrin</ForeName>\n                    <Initials>K</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Neurology, University of Erlangen-Nuremberg, Schwabachanlage 6, 90451, Erlangen, Germany. katrin@druschky.de.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bleich</LastName>\n                    <ForeName>Stefan</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Grohmann</LastName>\n                    <ForeName>Renate</ForeName>\n                    <Initials>R</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Psychiatry and Psychotherapy, Ludwig Maximilian University of Munich, Nussbaumstra\xc3\x9fe 7, 80336, Munich, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Engel</LastName>\n                    <ForeName>Rolf R</ForeName>\n                    <Initials>RR</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Psychiatry and Psychotherapy, Ludwig Maximilian University of Munich, Nussbaumstra\xc3\x9fe 7, 80336, Munich, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Toto</LastName>\n                    <ForeName>Sermin</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Neyazi</LastName>\n                    <ForeName>Alexandra</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Psychiatry, Social Psychiatry and Psychotherapy, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>D\xc3\xa4ubl</LastName>\n                    <ForeName>Barbara</ForeName>\n                    <Initials>B</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>KRH Psychiatrie Wunstorf, S\xc3\xbcdstr. 25, 31515, Wunstorf, Germany.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>KRH Psychiatrie Langenhagen, Langenhagen, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>St\xc3\xbcbner</LastName>\n                    <ForeName>Susanne</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Psychiatry and Psychotherapy, Ludwig Maximilian University of Munich, Nussbaumstra\xc3\x9fe 7, 80336, Munich, Germany.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>08</Month>\n                <Day>23</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Germany</Country>\n            <MedlineTA>Eur Arch Psychiatry Clin Neurosci</MedlineTA>\n            <NlmUniqueID>9103030</NlmUniqueID>\n            <ISSNLinking>0940-1334</ISSNLinking>\n        </MedlineJournalInfo>\n        <CitationSubset>IM</CitationSubset>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="N">AMSP programme</Keyword>\n            <Keyword MajorTopicYN="N">Adverse drug reactions</Keyword>\n            <Keyword MajorTopicYN="N">Antipsychotic drugs</Keyword>\n            <Keyword MajorTopicYN="N">Psychiatric inpatients</Keyword>\n            <Keyword MajorTopicYN="N">Severe parkinsonism</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>06</Month>\n                <Day>08</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>08</Month>\n                <Day>13</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>8</Month>\n                <Day>25</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2019</Year>\n                <Month>8</Month>\n                <Day>25</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>8</Month>\n                <Day>25</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31444566</ArticleId>\n            <ArticleId IdType="doi">10.1007/s00406-019-01060-7</ArticleId>\n            <ArticleId IdType="pii">10.1007/s00406-019-01060-7</ArticleId>\n        </ArticleIdList>\n        <ReferenceList>\n            <Reference>\n                <Citation>Pharmacopsychiatry. 2004 Mar;37 Suppl 1:S4-11</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15052509</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Handb Clin Neurol. 2007;84:399-416</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18808960</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Intern Med. 1994 May 23;154(10):1113-7</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7910451</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Curr Neuropharmacol. 2017 Nov 14;15(8):1192-1207</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28412910</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Med. 1995 Jul;99(1):48-54</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7598142</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Pharmacol Exp Ther. 1997 Jan;280(1):73-82</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8996184</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>World J Biol Psychiatry. 2019 Nov;20(9):732-741</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">30058414</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Nervenarzt. 2005 Jun;76(6):756-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15959751</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Public Health Nations Health. 1965 Aug;55:1170-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14326412</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Stat Med. 1993 May 15;12(9):809-24</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8327801</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurologist. 2017 Jan;22(1):24-28</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">28009769</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacopsychiatry. 2000 Sep;33 Suppl 1:34-42</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11072763</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur J Clin Pharmacol. 2001 Jul;57(4):327-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11549212</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>CNS Drugs. 2006;20(5):389-409</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16696579</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Neurol. 2012 Mar;8(1):15-21</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">22523509</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Pharmacopsychiatry. 2004 Mar;37 Suppl 1:S54-64</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">15052515</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Arch Intern Med. 2005 Sep 12;165(16):1882-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">16157833</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Psychopharmacol. 2008 Apr;28(2):203-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">18344731</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Aust N Z J Psychiatry. 2011 Mar;45(3):193-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21142850</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Am Med Assoc. 1956 May 19;161(3):214-8</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">13318904</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Prog Neuropsychopharmacol Biol Psychiatry. 2003 Oct;27(7):1091-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14642969</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Neuropsychopharmacol. 2013 Jul;16(6):1205-18</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23199972</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Am J Psychiatry. 2004 Jan;161(1):160-3</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">14702266</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">2841426</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2003 May 10;361(9369):1581-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">12747876</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Yonsei Med J. 1993 Jun;34(2):179-90</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7691017</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Lancet. 2013 Sep 14;382(9896):951-62</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23810019</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Psychopharmacol. 2014 Feb;34(1):36-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24145218</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurologia. 1996 Jan;11(1):10-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">8714170</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>CNS Drugs. 2002;16(1):23-45</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11772117</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Age Ageing. 1989 May;18(3):208-10</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">2675581</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Br Med J. 1969 Mar 1;1(5643):531-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">5764699</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Fundam Clin Pharmacol. 2000 Nov-Dec;14(6):529-39</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">11206702</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Indian J Psychiatry. 2014 Apr;56(2):197-9</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">24891713</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Neurology. 1999 Mar 10;52(4):782-5</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">10078728</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Psychol Med. 1980 Feb;10(1):55-72</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">6104342</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mov Disord. 1999 Jan;14(1):128-31</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9918355</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>J Clin Psychiatry. 1998 Feb;59(2):69-75</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">9501888</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Acta Psychiatr Scand. 1993 Dec;88(6):395-402</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">7508675</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Compr Psychiatry. 1982 Nov-Dec;23(6):567-71</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">6130891</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Mov Disord. 2017 Feb;32(2):227-234</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">27779780</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Postgrad Med J. 2009 Jun;85(1004):322-6</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">19528308</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Eur Arch Psychiatry Clin Neurosci. 2014 Mar;264(2):131-41</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">23835526</ArticleId>\n                </ArticleIdList>\n            </Reference>\n            <Reference>\n                <Citation>Int J Neuropsychopharmacol. 2012 Jul;15(6):739-48</Citation>\n                <ArticleIdList>\n                    <ArticleId IdType="pubmed">21777511</ArticleId>\n                </ArticleIdList>\n            </Reference>\n        </ReferenceList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'